Cargando…
Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications
BACKGROUND: As the treatment indications for the Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) portfolio continue to expand and diversify, injectors new to the range or those who are expanding the treatments they offer may be unsure of the optimal product and injection technique for spec...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435881/ https://www.ncbi.nlm.nih.gov/pubmed/34526796 http://dx.doi.org/10.2147/CCID.S311017 |
_version_ | 1783751893717090304 |
---|---|
author | van Loghem, Jani Sattler, Sonja Casabona, Gabriela Cotofana, Sebastian Fabi, Sabrina Guillen Goldie, Kate Gout, Uliana Kerscher, Martina Lim, Ting Song de Sanctis Pecora, Carla Sattler, Gerhard Trindade de Almeida, Ada Wanitphakdeedecha, Rungsima Werschler, Philip Pavicic, Tatjana |
author_facet | van Loghem, Jani Sattler, Sonja Casabona, Gabriela Cotofana, Sebastian Fabi, Sabrina Guillen Goldie, Kate Gout, Uliana Kerscher, Martina Lim, Ting Song de Sanctis Pecora, Carla Sattler, Gerhard Trindade de Almeida, Ada Wanitphakdeedecha, Rungsima Werschler, Philip Pavicic, Tatjana |
author_sort | van Loghem, Jani |
collection | PubMed |
description | BACKGROUND: As the treatment indications for the Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) portfolio continue to expand and diversify, injectors new to the range or those who are expanding the treatments they offer may be unsure of the optimal product and injection technique for specific facial areas. Each product in the CPM-HA portfolio has been intentionally designed to provide the best physical properties for a specific indication and target tissue. This document has been developed to provide a comprehensive, one-stop reference for clinicians using the portfolio. METHODS: An international panel of experts in the field of aesthetic medicine convened to develop guidelines on effective and safe injection technique when performing treatments with the CPM-HA range of soft-tissue fillers. RESULTS: Consensus members considered treatment indications in the upper, middle and lower face. Landmark deficiencies and anatomical considerations are described for each indication and consensus recommendations provided on the optimal product, injection depth and treatment technique. This is supplemented by the experts advice on avoidance of complications. Throughout, an evidence-based approach to selection of products and injection techniques is provided. The result is a fully tailored approach to a range of indications covering the full portfolio of CPM-HA products, including the newest addition for skin revitalization. CONCLUSION: The recommendations in this consensus document are provided to assist clinicians in the selection of CPM-HA products, administration techniques and depths of injection with the aim of providing seamless and natural treatment results, enhanced safety and patient satisfaction. |
format | Online Article Text |
id | pubmed-8435881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84358812021-09-14 Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications van Loghem, Jani Sattler, Sonja Casabona, Gabriela Cotofana, Sebastian Fabi, Sabrina Guillen Goldie, Kate Gout, Uliana Kerscher, Martina Lim, Ting Song de Sanctis Pecora, Carla Sattler, Gerhard Trindade de Almeida, Ada Wanitphakdeedecha, Rungsima Werschler, Philip Pavicic, Tatjana Clin Cosmet Investig Dermatol Expert Opinion BACKGROUND: As the treatment indications for the Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) portfolio continue to expand and diversify, injectors new to the range or those who are expanding the treatments they offer may be unsure of the optimal product and injection technique for specific facial areas. Each product in the CPM-HA portfolio has been intentionally designed to provide the best physical properties for a specific indication and target tissue. This document has been developed to provide a comprehensive, one-stop reference for clinicians using the portfolio. METHODS: An international panel of experts in the field of aesthetic medicine convened to develop guidelines on effective and safe injection technique when performing treatments with the CPM-HA range of soft-tissue fillers. RESULTS: Consensus members considered treatment indications in the upper, middle and lower face. Landmark deficiencies and anatomical considerations are described for each indication and consensus recommendations provided on the optimal product, injection depth and treatment technique. This is supplemented by the experts advice on avoidance of complications. Throughout, an evidence-based approach to selection of products and injection techniques is provided. The result is a fully tailored approach to a range of indications covering the full portfolio of CPM-HA products, including the newest addition for skin revitalization. CONCLUSION: The recommendations in this consensus document are provided to assist clinicians in the selection of CPM-HA products, administration techniques and depths of injection with the aim of providing seamless and natural treatment results, enhanced safety and patient satisfaction. Dove 2021-09-08 /pmc/articles/PMC8435881/ /pubmed/34526796 http://dx.doi.org/10.2147/CCID.S311017 Text en © 2021 van Loghem et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Expert Opinion van Loghem, Jani Sattler, Sonja Casabona, Gabriela Cotofana, Sebastian Fabi, Sabrina Guillen Goldie, Kate Gout, Uliana Kerscher, Martina Lim, Ting Song de Sanctis Pecora, Carla Sattler, Gerhard Trindade de Almeida, Ada Wanitphakdeedecha, Rungsima Werschler, Philip Pavicic, Tatjana Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title | Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title_full | Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title_fullStr | Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title_full_unstemmed | Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title_short | Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications |
title_sort | consensus on the use of hyaluronic acid fillers from the cohesive polydensified matrix range: best practice in specific facial indications |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435881/ https://www.ncbi.nlm.nih.gov/pubmed/34526796 http://dx.doi.org/10.2147/CCID.S311017 |
work_keys_str_mv | AT vanloghemjani consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT sattlersonja consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT casabonagabriela consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT cotofanasebastian consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT fabisabrinaguillen consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT goldiekate consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT goutuliana consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT kerschermartina consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT limtingsong consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT desanctispecoracarla consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT sattlergerhard consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT trindadedealmeidaada consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT wanitphakdeedecharungsima consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT werschlerphilip consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications AT pavicictatjana consensusontheuseofhyaluronicacidfillersfromthecohesivepolydensifiedmatrixrangebestpracticeinspecificfacialindications |